BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 528 filers reported holding BIO-TECHNE CORP in Q4 2023. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
About BIO-TECHNE CORP
Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.
Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.
In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.
Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.
Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $7,422,565 | -25.3% | 103,595 | -26.6% | 0.02% | -23.1% |
Q1 2024 | $9,938,541 | +178.8% | 141,193 | +205.6% | 0.03% | +116.7% |
Q4 2023 | $3,565,216 | +955.7% | 46,205 | +831.4% | 0.01% | +500.0% |
Q3 2023 | $337,696 | -91.3% | 4,961 | -89.6% | 0.00% | -86.7% |
Q2 2023 | $3,883,251 | +3.5% | 47,571 | +14.3% | 0.02% | +66.7% |
Q1 2023 | $3,750,663 | +12.6% | 41,626 | +3.5% | 0.01% | -57.1% |
Q4 2022 | $3,331,789 | +14.5% | 40,200 | +292.2% | 0.02% | -40.0% |
Q3 2022 | $2,911,000 | -10.9% | 10,250 | +8.7% | 0.04% | -2.8% |
Q2 2022 | $3,268,000 | -15.8% | 9,427 | +5.2% | 0.04% | -40.0% |
Q1 2022 | $3,883,000 | -14.2% | 8,965 | +2.6% | 0.06% | -13.0% |
Q4 2021 | $4,524,000 | +18.8% | 8,742 | +11.2% | 0.07% | -17.9% |
Q3 2021 | $3,809,000 | +14.7% | 7,860 | +6.5% | 0.08% | +15.1% |
Q2 2021 | $3,321,000 | +18.5% | 7,377 | +0.5% | 0.07% | +9.0% |
Q1 2021 | $2,802,000 | +19.6% | 7,337 | -0.5% | 0.07% | -10.7% |
Q4 2020 | $2,342,000 | +20.1% | 7,376 | -6.3% | 0.08% | -6.2% |
Q3 2020 | $1,950,000 | +11.0% | 7,873 | -11.0% | 0.08% | -32.2% |
Q1 2019 | $1,757,000 | +42.2% | 8,850 | +3.6% | 0.12% | +42.2% |
Q4 2018 | $1,236,000 | -36.8% | 8,544 | -10.9% | 0.08% | -39.0% |
Q3 2018 | $1,957,000 | +51.9% | 9,587 | +10.2% | 0.14% | +43.2% |
Q2 2018 | $1,288,000 | – | 8,703 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 46,500 | $16,119,000 | 8.75% |
Montanaro Asset Management Ltd | 93,950 | $32,567,000 | 4.90% |
Jackson Square Partners, LLC | 556,157 | $192,786,000 | 4.50% |
STONE RUN CAPITAL, LLC | 22,405 | $7,767,000 | 3.91% |
Ownership Capital B.V. | 655,654 | $227,276,000 | 3.90% |
Brown Capital Management | 839,587 | $291,034,000 | 3.90% |
Sandhill Capital Partners LLC | 97,382 | $33,757,000 | 3.61% |
DF DENT & CO INC | 684,026 | $237,111,000 | 3.34% |
Westwind Capital | 27,946 | $9,687,000 | 3.17% |
MAIRS & POWER INC | 655,930 | $227,371,000 | 2.72% |